Income Tax Expense (Benefit) in USD of Enveric Biosciences, Inc. from Q2 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enveric Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q2 2010 to 2024.
  • Enveric Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.73K.
  • Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2024 was $8.93K, a 69.1% decline from 2023.
  • Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $28.9K.
  • Enveric Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.49K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Enveric Biosciences, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.73K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q3 2023 $6.6K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q3 2020 $416K -$27.9K -$26.8K -2511% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $443K $17.5K +$895 +5.4% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $442K $21.9K +$53.1K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $389K $404K Oct 1, 2019 Dec 31, 2019 10-K/A 2020-08-12
Q3 2019 -$1.07K -$26K -104% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $16.6K +$16.6K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$31.2K -$31.2K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $24.9K +$24.9K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $0 -$2.02K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 -$41.7K $0 +$128K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$170K $0 -$43.5K -100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$127K $2.02K +$1.75K +635% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q4 2015 -$128K -$43.8K +$114K +72.3% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 -$242K -$128K -$129K -197731% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$114K $43.5K -$115K -72.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $825 $275 -$8 -2.83% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $833 -$158K -$159K -10979% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-31
Q3 2014 $160K $65.00 +$65.00 Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $160K $158K +$158K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-18
Q1 2014 $1.73K $283 +$283 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $1.45K $1.45K -$181 -11.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $1.63K $0 -$300 -100% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $1.93K $0 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $1.93K $0 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $1.93K $1.63K -$354 -17.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $2.29K $300 +$300 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 $1.99K $0 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $1.99K $0 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $1.99K $1.99K Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 $0 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $0 $0 Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-10
Q3 2010 $0 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02

Enveric Biosciences, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.93K -$20K -69.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $28.9K +$30.4K Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 -$1.49K +$7.45M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$7.45M* Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
2019 $389K -$5.96M Jan 1, 2019 Dec 31, 2019 10-K/A 2020-08-12
2018 $6.35M* +$8.74M Jan 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
2017 -$2.39M* +$1.36M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-26
2016 -$3.75M* -$3.62M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$128K -$129K -15521% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
2014 $833 -$617 -42.6% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-31
2013 $1.45K -$481 -24.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $1.93K -$54 -2.72% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 $1.99K -$1.58K -44.3% Jan 1, 2011 Dec 31, 2011 10-K 2013-02-28
2010 $3.57K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.